Evolution of multiple sclerosis spasticity-associated symptoms: latest data. - Wikidata - wikimedia - TriplyDB

Evolution of multiple sclerosis spasticity-associated symptoms: latest data.

Evolution of multiple sclerosis spasticity-associated symptoms: latest data.

http://www.wikidata.org/entity/Q31144052

about

Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis-related spasticity.

P2860

Q47294789-CCB4E08B-A9D2-4524-91D1-99074567771C Q55025049-8812D2AB-AFBF-455B-B9EA-B6535C764BA3

P2860

Evolution of multiple sclerosis spasticity-associated symptoms: latest data.

http://www.wikidata.org/entity/Q31144052

description

2016 nî lūn-bûn

@nan

2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Evolution of multiple sclerosis spasticity-associated symptoms: latest data.

@ast

Evolution of multiple sclerosis spasticity-associated symptoms: latest data.

@en

type

label

Evolution of multiple sclerosis spasticity-associated symptoms: latest data.

@ast

Evolution of multiple sclerosis spasticity-associated symptoms: latest data.

@en

prefLabel

Evolution of multiple sclerosis spasticity-associated symptoms: latest data.

@ast

Evolution of multiple sclerosis spasticity-associated symptoms: latest data.

@en

P1433

Q31144052-52B54A42-DDCC-4E34-BDE6-F8DD37F58553

P1476

Q31144052-2F847997-D8E2-44E2-9A3C-BFE86C7FB724

P2093

Q31144052-8722BC84-7DC0-4DB0-83D2-1A975FADE003

P2860

Q31144052-00C93934-89CE-405E-B3AA-91214673E291

Q31144052-26C24520-A516-440B-9A2E-A118E0C9B964

Q31144052-2AD836A1-2806-4E24-80F1-C663B05C2D32

Q31144052-338D0CE5-6852-4C24-AC06-D25513C98217

Q31144052-380DF111-3D83-43B8-8FEE-0D65864F50C8

Q31144052-7F625412-0A56-4B4D-B16F-92C38329A23C

Q31144052-8E607683-BBDC-4D60-AF9C-510B8886D89B

Q31144052-B1D07DB7-16AD-4C9C-B790-FD9E8ADD9EC8

Q31144052-DBC7E4C2-7CC7-4476-8BE4-9757638CAC02

P304

Q31144052-1EB00037-59C6-42E8-A78C-ADE865F19665

P31

Q31144052-D4F9F765-3954-4145-870D-C7FE51DF35FD

P356

Q31144052-2121826D-B2FE-484B-9433-07D4D9F1F633

P433

Q31144052-C6AB775A-4AE8-462C-A8A8-C8D16A6B249E

P478

Q31144052-58033BB5-BED2-4022-B367-F4036B007E89

P577

Q31144052-ABC52FDC-DC5A-49A5-A016-8545F8114F53

P698

Q31144052-A7A84C7A-00D1-499C-A52E-9511FCB4F683

P356

P1433

Neurodegenerative disease management

P1476

Evolution of multiple sclerosis spasticity-associated symptoms: latest data.

@en

P2093

Peter Flachenecker

http://www.w3.org/2001/XMLSchema#string

P2860

Effectiveness and Tolerability of THC/CBD Oromucosal Spray for Multiple Sclerosis Spasticity in Italy: First Data from a Large Observational Study.

Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis.

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity

Nabiximols (THC/CBD oromucosal spray, Sativex®) in clinical practice--results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity.

Prevalence and treatment of spasticity reported by multiple sclerosis patients.

Symptomatology of MS: results from the German MS Registry.

Spasticity in patients with multiple sclerosis--clinical characteristics, treatment and quality of life.

A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis.

P304

9-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/NMT-2016-0047

http://www.w3.org/2001/XMLSchema#string

P433

6s

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27874495

http://www.w3.org/2001/XMLSchema#string